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The Policy-Practice Gap
Regarding Children in Contact
with a Tuberculosis Case
The prevention, diagnosis, and treatment
of tuberculosis (TB) in children are of
particular importance in developing coun-
tries where TB is endemic [1]. Child
contacts of an adult with sputum smear–
positive TB are at high risk of infection with
Mycobacterium tuberculosis and subsequent
early progression to TB disease [2]. Anti-
tubercular antibiotic prophylaxis is highly
effective in preventing progression to disease
in children infected with M. tuberculosis,w i t h
protection of up to 90% [3]. Therefore, the
World Health Organization (WHO) recom-
mends that all children ,5 years who are a
household contact of a sputum smear–
positive case should receive preventive
treatment, once TB disease has been ruled
out [4]. Box 1 summarises the 2006 WHO
recommendation for contact management
as a symptom-based approach, whereby
most child contacts can be placed immedi-
ately on preventive treatment without the
need for formal clinical evaluation.
Of concern, the WHO recommendation
for the management of child contacts of a
sputum smear–positive index case is rarely
implemented, despite being incorporated
widely into National TB Control Program
(NTP) guidelines [5–7]. Possible reasons for
this include that limited NTP resources are
focused on the management of TB disease,
the perceived need for specialised services
and investigations to provide adequate
clinical evaluation, and concerns regarding
re-infection and poor adherence in relation
to the development of resistance [7–10].
Furthermore, attempts to implement the
policy have been characterised by low
attendance for screening, poor adherence
to preventive treatment, and high default-
ing rates [9,11,12]. Specific barriers in
relation to preventive treatment that have
been identified include issues of knowledge,
understanding, and perception in TB
patients and TB program staff [5,13], lack
of an appropriate management structure
and necessary tools [6], treatment side
effects [14], transport difficulties, and cost
[10,13,14]. However, the literature with
respect to barriers in the management of
child contacts of TB cases in developing
countries is relatively sparse.
It is clear that there is a policy-practice
gap that needs to be addressed. Here, we
propose an evidence-based approach to
close this gap and show how this can lead
to the management of child contacts of TB
cases being properly incorporated into
NTP activities, applied in the community
and clinic, and formally evaluated.
Closing the Gap
We propose the employment of an
innovative combination of a health needs
assessment (HNA) public health frame-
work, integrated research tools, and a
clinical evaluation plan in those child
contacts with symptoms. The key steps of
an HNA as a public health framework are
described in Figure 1 [15]. An initial
situational analysis of current practice is
followed by identification of the gaps
between current and ideal practice. This
is followed by a process whereby options
for filling the gaps are considered and the
most appropriate recommended. These
are then brought together and implement-
ed as new routine practice. Once imple-
mented, the new service is monitored and
evaluated. This public health framework
has been used to match health needs and
provision in populations [15]. Quantita-
tive and qualitative research tools have
been integrated to provide a clear under-
standing of need [16]. The framework can
be applied to specific health issues. For
example, it has been adopted as a tool to
develop a way forward for the rational use
of oxygen in child pneumonia in West
Africa [17,18]. To the best of our
knowledge, other than the step of situa-
tional analysis [5], it has not been applied
to child TB case contact management.
Situational Analysis
The indicators that should be included
in the situational analysis of the manage-
ment of child contacts of adult TB cases
are summarised in Table 1. These cover
basic demographic details of the TB cases
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the performance and capacity of the
system to deliver proper evaluation and
management of TB contacts, key aspects
of drug supply and quality, adherence and
defaulting in relation to preventive and
curative treatment, treatment outcome,
attitudes and acceptability of child contact
management by staff and primary care-
givers, and cost analyses.
The research tools that are required
include relatively large cross-sectional and
cohort studies as well as qualitative
methods and focused cost questionnaires.
We note that longitudinal follow-up of
those placed on preventive treatment
currently offers limited information at the
situational analysis stage if preventive
treatment is not practiced. We propose a
single cohort study with recruitment
extended to meet the requirements of
each question (up to a maximum of
2,000 contacts for the disease outcome)
and sufficient follow-up time of 1 year.
Such an approach enables risk factors and
barriers related to particular gaps to be
identified (Table 2) and fed into the
evidence base for the options process
(Table 3). It is not absolutely necessary to
have a secondary disease outcome indica-
tor, as the efficacy of preventive therapy
can be assumed from the literature.
However, a baseline understanding of the
incidence rate of secondary disease in a
particular population is valuable for future
comparisons. Cost analyses include both
direct (costs to the patient/contacts and
the health care provider to access care and
provide treatment) and indirect costs (non-
health care costs that result from engage-
ment with the health system). By collecting
direct and indirect cost information for
exposed children who have preventive
treatment and those who do not, the
importance of economic barriers to
screening and therapy can be established.
For such an evaluation, an asset-based
measure of wealth can be used to estimate
the extent to which financial constraints
impact on caregivers’ decisions [19]. The
qualitative studies provide new insights
into factors that may be important with
respect to attendance at screening and
adherence to medication, as well as
caregiver and staff knowledge and atti-
tudes.
Gap Analysis
During the gap analysis, disparities
between current and ideal practices are
quantified for each component. Table 2
shows examples of how each gap can be
identifiedanddescribed.Thisisundertaken
for each component of the situational
analysis. In most situations, it is expected
that the extent of the gap can be clearly
defined. However, it may be necessary to
estimate the gap based on limited informa-
tion.Ifthisestimateistooimprecise,further
research may be required to define the gap.
Options Analysis
Following the identification of gaps
between the current and ideal practices,
options for closing these are reviewed.
Each option is considered for scientific
evidence of efficacy, feasibility in the
specific setting, and cost evaluation from
case contact household and societal per-
spectives. For each gap, an option to take
forward for implementation is then rec-
ommended. Table 3 shows how the
options can be presented.
Besides indicating the best possible
intervention to improve the program, the
options analysis will also lead to identifi-
cation of information gaps in the literature
where options for addressing an aspect of
the current situation are unclear or
unproven. In such circumstances, research
may need to be undertaken to provide the
necessary information. These research
projects may range from simple cross-
sectional evaluations to randomised inter-
vention trials with follow-up. However, it
is anticipated that a ‘‘best guess’’ for a
decision on a way forward in some areas
may simply be pragmatically necessary to
develop a multi-component management
Summary Points
N Children in contact with an adult with smear-positive tuberculosis (TB) are at
high risk of being infected themselves and progressing to TB disease.
N The World Health Organization recommends that such children, if aged under 5
years, should receive preventive treatment once TB disease has been ruled out.
N This policy is rarely implemented and attempts to do so have had disappointing
results.
N We propose a new approach using a health needs assessment framework,
research tools, and a strategy for clinical evaluation.
N We show how this approach could be applied and evaluated by National TB
Control Programs.
Box 1. A symptom-based approach to child contacts of adult TB
cases
Children who are household contacts of a sputum smear–positive adult TB case
are initially evaluated in the community. If asymptomatic and less than 5 years of
age, they are immediately commenced on preventive treatment. If they have
symptoms consistent with TB disease they are referred for clinical workup. Those
diagnosed with TB disease undergo a full course of multi-drug treatment. Those
less than 5 years of age who are not diagnosed with TB disease receive preventive
treatment.
2006 WHO Guidance for National Tuberculosis Programmes on the Management of
Tuberculosis in Children.
Figure 1. A health needs assessment
framework for addressing the policy-
practice gap in the management of child
contacts of TB cases.
doi:10.1371/journal.pmed.1001105.g001
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time.
Clinical Evaluation of Child Contacts
with Symptoms of TB Disease
A child TB contact management plan
with a view to routine use of preventive
treatment in those without symptoms of
disease needs to include an approach to
the diagnosis/exclusion of TB disease in
symptomatic contacts of any age. The
implication of using the WHO symptom-
based approach is that those children who
are asymptomatic can go directly onto
preventive treatment, while those with
defined symptoms immediately enter a
clinical evaluation plan that either leads to
full TB treatment for disease or, if active
disease is excluded, to commencement of
preventive treatment (see Box 1). Indeed,
the process of contact screening will
Table 1. Indicators of system performance in child TB case contact management.
Parameter Indicator Specific Study Details/Design
Screening and
diagnosis
Number of child contacts of TB cases and their basic characteristics Routinely record details of all cases and their household contacts
Proportion of children who attend for screening in community
and at the clinic
Cohort study of consecutive household contacts (n=500)
a
Proportion of children diagnosed with or without TB that are
misclassified
Review of all case notes over the previous 6 months
Proportion of children who require clinical follow up to clarify
diagnosis
Review of all case notes over the previous 6 months
Proportion of those who require follow-up that complete it to a
diagnostic decision
Review of all case notes over the previous 6 months
Medication Availability and consistency of medicine supply Annual survey of supply outlets
Current quality Annual analysis of drug quality in random samples
Current cost Annual review of cost
Adherence/
acceptability
Proportion of adherent children Cohort of consecutively treated children (n=500)
b
Proportion of temporary default children Cohort of consecutively treated children (n=500)
b
Proportion of permanent default children Cohort of consecutively treated children (n=1,000)
b
Patient/parent acceptability Qualitative survey of caregivers (n=30-50)
Clinician and staff acceptability Qualitative survey of staff from various disciplines (n=30–50)
Treatment
outcome
Number of children (,5 years) on preventive treatment who
develop TB
Cohort of consecutively treated children, 1 year follow-up
(n=2,000)
c
Proportion with side effects of preventive treatment Cohort of consecutively treated children (n=200)
d
Proportion stopping treatment because of side effects of medication Cohort of consecutively treated children (n=200)
d
Cost Cost to clinic Survey of key staff (n=10)
Direct and indirect costs to child and caregiver Survey of primary caregivers (n=50)
aIndex cases interviewed at diagnosis to identify case, contact, and household factors associated with non-attendance. A study of 500 contacts is advised, assuming
non-attendance of at least 20%.
bCohort study of 500 enables evaluation of risk factors for non-adherence (taking ,80% of doses) and temporary defaulting (not taking medicine for at least one week),
assuming at least 20% non-adherence; enlarged to 1,000 assuming permanent default rate is at least 10%.
cn=2,000 is estimated to identify ‘‘secondary cases’’ on the basis of 60%–90% efficacy of preventive therapy, an assumption of .80% adherence and a natural
progression off treatment of up to 20% over one year [2].
dCohort of 200 is based on an expected incidence of symptomatic hepatotoxicity due to IPT of ,10% over a treatment course in children [25].
doi:10.1371/journal.pmed.1001105.t001
Table 2. Possible examples of identification of gaps with respect to IPT and possible relevant site-specific risk factors identified
from the situational analysis.
Issue Current Reality Ideal Gap Site-Specific Factors Identified
Screening and diagnosis Proportion attending
screening 30%
Target .80% to
attend screening
a
.50% of expected case
contacts are not screened
Knowledge in TB cases and staff,
cost of attendance and travel time
Proportion of children
screened that are
diagnosed with TB
disease 50%
,10% are expected to
have TB disease at
screening [10]
.40% of children evaluated
are inappropriately diagnosed
with TB
Overuse and over-diagnosis of X-rays
Adherence/acceptability 40% adherence to
preventive treatment
Target .80%
a adherence
to preventive treatment
.40% excess of non-
adherent children
Poor adherence, especially in the second
half of treatment due to cumulative
travel, time, and cost factors
aTargets for adherence to screening and treatment suggested here are broadly in line with WHO targets for the identification and management of tuberculosis cases.
doi:10.1371/journal.pmed.1001105.t002
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TB because of the high prevalence of
disease in contacts of any age [20]. The
International Union Against Tuberculosis
and Lung Disease has developed training
tools that include management algorithms
for the evaluation of symptomatic children
[21]. It is recommended that each NTP
develop a clinical evaluation plan using the
following steps:
1. Design and implementation of a clin-
ical management algorithm following
input from paediatric services at the
provincial level.
2. A clear decision pathway leading to
anti-TB treatment or preventive treat-
ment.
3. A follow-up plan.
4. Evaluation of the overall strategy.
Implementation and Evaluation
From the options analysis, a compre-
hensive strategy is then developed for
implementation. This can be piloted and
rolled out after modification. After imple-
mentation, a monitoring and evaluation
strategy is put in place using measurable
indicators and key research tools as
described in Table 1. A before and after
indicator approach is well suited to multi-
component public health intervention in
TB control [22], although more complex
implementation research tools could be
used [23]. It is anticipated that such an
‘‘effectiveness study’’ would be conducted
over approximately 2 years. Longer-term
effectiveness evaluation could be incorpo-
rated through various methods. For ex-
ample, the same studies could be repeated,
or there may be a focus on under-
performing areas with other areas subject
to less intensive study.
Operational Considerations
Operational research is, by definition,
intimately related to the operations of the
NTP. Therefore, the implementation plan
in particular requires project management
and funding to be coordinated between
operations managers and operational re-
searchers. Discussions should be held at an
early stage regarding the coordination of
changes to operational activities and the
accompanying operational research. One
solution is to establish a steering commit-
tee of key people [24]. This group needs to
be carefully constructed, with expertise in
operations and operational research, and
have clear accountabilities and terms of
reference. A key task of this steering group
is to ensure that the new strategy is
consistent with and incorporated into the
National Guidelines, that it is successfully
rolled out across the country, and is
evaluable and sustainable.
Conclusions
There is a significant gap between
policy and practice in relation to child
contacts of TB cases across the developing
world. Here, we have proposed a way
forward to address this problem, combin-
ing a HNA framework with research tools
and a workable approach to clinical
evaluation. We envisage that this ap-
proach will help close the gap between
policy and practice in TB control in
children. As such, it will contribute to the
achievement of Millennium Development
Goal number four, to reduce child mor-
tality. In addition, it will help reduce the
Table 3. Examples of possible options analyses and recommendations to address gaps that are identified in the management of
child contacts of adult TB cases.
Problem Options Evidence Analysis Feasibility Analysis Recommendation
Low screening
attendance due
to knowledge
gap, distance,
and cost issues
1. Educational video Well received in relation to TB disease [26] Subject to equipment and
expertise availability
Develop and evaluate educational
video for TB patients and contacts
2. Decentralised sym-
ptom-based screening in
the community and at
community health centres
Decentralised provision of TB treatment
improves uptake and completion [27];
symptom-based screening is safe [28]
Low cost; increased
community clinic work
load.
Symptom-based screening in the
community; clinical evaluation and
management at community clinics
3. Cash transfer to
stimulate attendance and
subsequent adherence
Conditional cash transfer systems
increase attendance at preventive
treatment programmes [29]. Cost
effectiveness is unclear.
Significant cost implications
up front that need to be
addressed
Pilot a cash transfer intervention
with before and after evaluation,
subject to finances
Over-diagnosis
of TB disease
in children
1. Specialised training in
diagnosis of TB disease in
children
Limited published evidence of effect on
diagnostic accuracy
2 day centralised training
courses are the most cost-
effective
Introduce 2- to 5-day in-country
training in diagnosis of child TB
disease annually
2. Remote interpretation
of digital chest X-rays by
WHO-accredited
radiologists
Quality of X-rays and reading is acceptable
and reliable
High cost of installation
of digital X-ray machines
Consider digital X-ray and remote
reading if high levels of over-
diagnosis persist after training
Low adherence 1.Changing therapy
from 6 months INH to
3 months RIF and INH
Efficacy is equivalent in adults but unclear
if side effect profile is worse for 3-month
regimen [30]. Some evidence of equivalent
efficacy and improved adherence in
children [8].
Lower cost; one extra
medicine
Cohort study required for side effect
profile in children before a change
to 3-month regimen
2. Parallel DOTs for
children on preventive
treatment with DOTs
for index case
Some evidence that DOTs for preventive
treatment would be effective [8]
Increased cost to provide
DOTs, although economies
of scale optimised if in
parallel to index case DOTs
Introduce a modified DOTs
programme for preventive
treatment in parallel and
overlapping with index case DOTs.
Before and after evaluation.
DOT, directly observed therapy; INH, Isoniazid; RIF, rifampicin.
doi:10.1371/journal.pmed.1001105.t003
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nity, which is necessary for TB elimina-
tion. Since this is an operations and
operational research plan it will need to
be carefully coordinated with local NTP
activities, and a steering committee is
strongly advised to facilitate this. A limited
number of urban and rural sites per
country need to adopt the approach
described here, as resulting new routine
practice can be rolled out more widely.
Evidence from the application of the
approach in different settings will also be
able to inform the options analyses of
others. Ultimately, the solutions that are
identified and implemented on the basis of
this approach will need to be sustainable.
A key component will be building the
capacity of local staff in operational
research. Proper integration of operational
research into NTP activities will only
enhance global TB control.
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